Amid concerns about the spread and mutant virus of Corona 19, the decision was made ahead of time… Executive Committee “approved soon”
![The image of the bottle with the US pharmaceutical company Modena logo and the novel coronavirus infection (Corona 19) vaccine. [로이터=연합뉴스 자료사진]](https://i0.wp.com/img6.yna.co.kr/photo/reuters/2021/01/05/PRU20210105097601055_P4.jpg?w=560&ssl=1)
The image of the bottle with the US pharmaceutical company Modena logo and the novel coronavirus infection (Corona 19) vaccine. [로이터=연합뉴스 자료사진]
(Brussels = Yonhap News) Correspondent Kim Jong-un = The European Medicines Agency (EMA) recommended conditional marketing approval of a novel coronavirus infection (Corona 19) vaccine developed by the US pharmaceutical company Modena on the 6th (local time).
This is the second time on the 21st of last month after recommending conditional marketing approval for the COVID-19 vaccine jointly developed by US pharmaceutical company Pfizer and German Bioentech.
EMA announced that it recommends approval of the use of the vaccine for people 18 years of age or older after the Modena vaccine evaluation meeting.
The final official approval decision is now made by the European Commission, a member of the EU, and once approved, each Member State can begin vaccination.
“Now we will work at full speed to approve it and make it available within the EU”, welcoming the decision to Twitter, the head of the EU administration, Urzula Fonderaien.
“EU Commission approval is coming soon,” said on Twitter, EU Commissioner Stella Kyriachides Health Commissioner.
The EU Commission made a decision to approve the Pfizer-Bioentech vaccine on the day of the EMA recommendation last month. In EU member states, vaccination began in earnest on the 27th of last month.
The United States, Canada and Israel have already approved the Modena vaccine following the Pfizer-Bioentech vaccine.
The recommendation for approval of Modena came amid rising criticism that the spread of Corona 19 continues in 27 EU member states with a population of 450 million and concerns about the mutant virus are growing.
Vaccination rates vary widely among member countries. According to the Associated Press, France received 500 vaccines in the first week, while Germany received 200,000 vaccines. The Netherlands was the last member nation to start vaccination on this day.
In the past week since vaccination began in the EU, there are hundreds of thousands of Europeans who have been vaccinated, Reuters said.
![[AFP=연합뉴스 자료사진]](https://i0.wp.com/img8.yna.co.kr/photo/etc/af/2020/12/25/PAF20201225128301055_P4.jpg?w=560&ssl=1)
[AFP=연합뉴스 자료사진]
EMA originally planned to hold a modder or vaccine evaluation meeting on the 12th, but it has pushed the schedule forward to that day amid pressure from member states for prompt approval.
EMA held an unscheduled meeting on the 4th to discuss whether to approve modders or vaccines, but it did not come to a conclusion and reunited that day.
Previously, Modena announced that the final analysis of its vaccine phase 3 clinical trial showed 94.1% of the preventive effect and applied for emergency approval to EMA.
Like Pfizer-Bioentech, Modena vaccine was developed using’messenger ribonucleic acid’ (mRNA, messenger RNA) containing the genetic information of the virus. You can keep it.
The EU signed a contract to purchase 160 million doses of the vaccine with Modena.
The Dutch medicines agency CBG said it expects Modena vaccine to be effective against the mutant virus found in the UK, but it should be confirmed by further research, Reuters said.
Unauthorized reproduction-redistribution prohibited>
2021/01/06 23:01 sent